Cargando…

Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation

BACKGROUND: The characteristics of Waardenburg syndrome (WS) as a scarce heritable disorder are sensorineural hearing loss and deficits of pigmentation in the skin, hair, and eye. Here, clinical features and detection of the mutation in the MITF gene of WS2 patients are reported in a sizable Iranian...

Descripción completa

Detalles Bibliográficos
Autores principales: Zardadi, Safoura, Rayat, Sima, Hassani Doabsari, Maryam, Keramatipour, Mohammad, Morovvati, Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451132/
https://www.ncbi.nlm.nih.gov/pubmed/34544414
http://dx.doi.org/10.1186/s12920-021-01074-y
_version_ 1784569777523523584
author Zardadi, Safoura
Rayat, Sima
Hassani Doabsari, Maryam
Keramatipour, Mohammad
Morovvati, Saeid
author_facet Zardadi, Safoura
Rayat, Sima
Hassani Doabsari, Maryam
Keramatipour, Mohammad
Morovvati, Saeid
author_sort Zardadi, Safoura
collection PubMed
description BACKGROUND: The characteristics of Waardenburg syndrome (WS) as a scarce heritable disorder are sensorineural hearing loss and deficits of pigmentation in the skin, hair, and eye. Here, clinical features and detection of the mutation in the MITF gene of WS2 patients are reported in a sizable Iranian family. METHODS: A man aged 28-years represented with symptoms of mild unilateral hearing loss (right ear), complete heterochromia iridis, premature graying prior to 30 years of age, and synophrys. In this research, there was a sizable family in Iran comprising three generations with seven WS patients and two healthy members. Whole exome sequencing was applied for proband for the identification of the candidate genetic mutations associated with the disease. The detected mutation in proband and investigated family members was validated by PCR-Sanger sequencing. RESULTS: A novel heterozygous mutation, NM_198159.3:c.1026dup p.(Asn343Glufs*27), in exon 9 of the MITF gene co-segregated with WS2 in the affected family members. The variant was forecasted as a disease-causing variant by the Mutation Taster. According to the UniProt database, this variant has been located in basic helix-loop-helix (bHLH) domain of the protein with critical role in DNA binding. CONCLUSIONS: A frameshift was caused by a nucleotide insertion, c.1026dup, in exon 9 of the MITF gene. This mutation is able to induce an early termination, resulting in forming a truncated protein capable of affecting the normal function of the MITF protein. Helpful information is provided through an exactly described mutations involved in WS to clarify the molecular cause of clinical characteristics of WS and have a contribution to better genetic counseling of WS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01074-y.
format Online
Article
Text
id pubmed-8451132
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84511322021-09-20 Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation Zardadi, Safoura Rayat, Sima Hassani Doabsari, Maryam Keramatipour, Mohammad Morovvati, Saeid BMC Med Genomics Research BACKGROUND: The characteristics of Waardenburg syndrome (WS) as a scarce heritable disorder are sensorineural hearing loss and deficits of pigmentation in the skin, hair, and eye. Here, clinical features and detection of the mutation in the MITF gene of WS2 patients are reported in a sizable Iranian family. METHODS: A man aged 28-years represented with symptoms of mild unilateral hearing loss (right ear), complete heterochromia iridis, premature graying prior to 30 years of age, and synophrys. In this research, there was a sizable family in Iran comprising three generations with seven WS patients and two healthy members. Whole exome sequencing was applied for proband for the identification of the candidate genetic mutations associated with the disease. The detected mutation in proband and investigated family members was validated by PCR-Sanger sequencing. RESULTS: A novel heterozygous mutation, NM_198159.3:c.1026dup p.(Asn343Glufs*27), in exon 9 of the MITF gene co-segregated with WS2 in the affected family members. The variant was forecasted as a disease-causing variant by the Mutation Taster. According to the UniProt database, this variant has been located in basic helix-loop-helix (bHLH) domain of the protein with critical role in DNA binding. CONCLUSIONS: A frameshift was caused by a nucleotide insertion, c.1026dup, in exon 9 of the MITF gene. This mutation is able to induce an early termination, resulting in forming a truncated protein capable of affecting the normal function of the MITF protein. Helpful information is provided through an exactly described mutations involved in WS to clarify the molecular cause of clinical characteristics of WS and have a contribution to better genetic counseling of WS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01074-y. BioMed Central 2021-09-20 /pmc/articles/PMC8451132/ /pubmed/34544414 http://dx.doi.org/10.1186/s12920-021-01074-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zardadi, Safoura
Rayat, Sima
Hassani Doabsari, Maryam
Keramatipour, Mohammad
Morovvati, Saeid
Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation
title Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation
title_full Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation
title_fullStr Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation
title_full_unstemmed Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation
title_short Waardenburg syndrome type 2A in a large Iranian family with a novel MITF gene mutation
title_sort waardenburg syndrome type 2a in a large iranian family with a novel mitf gene mutation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451132/
https://www.ncbi.nlm.nih.gov/pubmed/34544414
http://dx.doi.org/10.1186/s12920-021-01074-y
work_keys_str_mv AT zardadisafoura waardenburgsyndrometype2ainalargeiranianfamilywithanovelmitfgenemutation
AT rayatsima waardenburgsyndrometype2ainalargeiranianfamilywithanovelmitfgenemutation
AT hassanidoabsarimaryam waardenburgsyndrometype2ainalargeiranianfamilywithanovelmitfgenemutation
AT keramatipourmohammad waardenburgsyndrometype2ainalargeiranianfamilywithanovelmitfgenemutation
AT morovvatisaeid waardenburgsyndrometype2ainalargeiranianfamilywithanovelmitfgenemutation